Heavy menstrual bleeding. Excessive and frequent menstruation with regular cycle
Conditions
Interventions
Intervention 1: Intervention group 1: Frankincense capsule and ibuprofen tablet will be prescribed for the patients, three times a day, from first to the last day of menstrual period. This order will
Treatment - Drugs
Placebo
Intervention group 1: Frankincense capsule and ibuprofen tablet will be prescribed for the patients, three times a day, from first to the last day of menstrual period. This order will be followed in t
Intervention group 2: Ginger capsule and ibuprofen tablet will be prescribed for the patients, three times a day, from first to the last day of menstrual period. This order will be followed in two con
Control group: Placebo capsule and ibuprofen tablet will be prescribed for the patients, three times a day, from first to the last day of menstrual period. This order will be followed in two consecuti
Sponsors
Vice chacellor for research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Outpatient women at the age of 18-45years; Regular 22- 35 day menstrual cycles; presence of menorrhagia based on Higham bleeding assessment chart (bleeding more than 80 ml per cycle, or more than 7 days); absence of moderate or severe anemia (hemoglobin greater than 10.5 milligrams per deciliter); The absence of uterine fibroma or being smaller than 5 cm; The absence of ovarian cysts; Not using hormonal drugs or any medication affecting menstrual bleeding (oral contraceptive pills and aspirin, warfarin); normal endometrial thickness in abdominal or trans vaginal ultrasound; The patient is not pregnant or during lactation. Exclusion criteria: pregnancy; breast feeding; taking hormonal drugs or mefenamic acid during their menstruation period; being allergic to ginger or frankincense; severe bleeding during menstruation period requiring emergency measures.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menstrual blood volume. Timepoint: The end of each menstrual cycle. Method of measurement: Pictorial Blood Loss Assessment (PBAC).;Time period (days) of menstrual bleeding. Timepoint: The end of each menstrual cycle. Method of measurement: Pictorial Blood Loss Assessment (PBAC). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRazieh Eshaghian
Isfahan University of Medical Sciences
Outcome results
None listed